申请人:Dehmlow Henrietta
公开号:US20050245515A1
公开(公告)日:2005-11-03
The invention relates to compounds of formula (I):
and pharmaceutically acceptable salts and pharmaceutically acceptable esters thereof, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, A, m, n and p are defined as in claim
1.
These compounds can be used as pharmaceutical compositions for the treatment of, for example, diabetes.
这项发明涉及式(I)的化合物:
以及其药学上可接受的盐和药学上可接受的酯,其中R
1
,R
2
,R
3
,R
4
,R
5
,R
6
,A,m,n和p的定义如权利要求书中所述。
这些化合物可用作治疗糖尿病等疾病的药物组合物。